This website is intended for healthcare professionals only
Specialities

Specialities

Respiratory Infections
Airway Diseases
Allergy
Asthma
Bronchiectasis
Bronchitis
Chronic Cough
COPD
COVID-19
Cystic Fibrosis
Idiopathic Pulmonary Fibrosis
Interstitial Lung Disease
Interventional Pulmonology
Lung Cancer
Pediatric Respiratory Medicine
Respiratory Tract Disorders
Pulmonary Embolism
Pulmonary Hypertension
Respiratory Intensive Care
Rhinosinusitis
Sleep Related Breathing Disorders
Lung Transplantation and Surgery
Ventilation
Lung Health
Rare Disease Day
Emphysema
Rare Diseases
Search

Trending Topic

Essential diagnostics for lung health in medical research and clinical care. Concept Pulmonary Function Tests, Chest X-ray, CT Scan, Bronchoscopy, Blood Gas Analysis
4 mins

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Tuberculosis Care in Isolation: Part Two of a Two-part Focus on Modern Tuberculosis Care

Juzar Ali, Priyanka U Jadhav, Amy Wolfe

Tuberculosis (TB) has risen once again, as of 2023, to return to being the world’s deadliest infectious disease. TB causes around one million deaths annually, leaving devastating impacts on patients and their communities.1 Historically, TB has been treated in separate TB clinics worldwide that are independent under public health systems, generally isolated from standard primary-care clinics. In […]

touchREVIEWS in Respiratory & Pulmonary Diseases. 2026;11(1):Online ahead of journal publication

Connect With Us:

Facebook
X (Twitter)
Instagram
Youtube
Linkedin

Molla Imaduddin Ahmed, ERS 2021: Advances in the Treatment of Cystic Fibrosis

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Sep 30th 2021

It was great to talk with Dr Molla Imaduddin Ahmed (Leicester Childrens’ Hospital, Leicester, UK) around the impact of CFTR modulator therapies and exciting advances in the treatment of cystic fibrosis.

Questions

  1. What has been the impact of cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapies on the treatment of cystic fibrosis (CF)? (0:20)
  2. What are the hot topics and latest research you are looking forward to exploring in cystic fibrosis during 2021? (1:36)

Disclosures: Molla Imaduddin Ahmed has nothing to disclose in relation to this video.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Victoria Jones.

Filmed as a highlight of ERS 2021 (Virtual).

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Molla Imaduddin Ahmed, ERS 2021: Tezacaftor/Ivacaftor Effect on Exercise Capacity in Adolescents with Cystic Fibrosis

It was a pleasure to speak with Dr Molla Imaduddin Ahmed (Leicester Childrens’ Hospital, Leicester, UK) around his abstract on ‘The impact of Symkevi (Tezacaftor/Ivacaftor) on exercise capacity in adolescents with CF.‘, which was presented at ERS International Congress 2021, 5-8 September 2021. Questions How useful is exercise capacity as a clinical endpoint for cystic […]

Advertisement

    • Related Videos in Cystic Fibrosis

    Latest articles videos and clinical updates - straight to your inbox

    Close Popup